Rev-RRE activity modulates HIV-1 replication and latency reactivation: Implications for viral persistence and cure strategies
The HIV-1 Rev-RRE regulatory axis plays a crucial role in viral replication by facilitating the nucleo-cytoplasmic export and expression of viral mRNAs with retained introns. In this study, we investigated the impact of variation in Rev-RRE functional activity on HIV-1 replication kinetics and reactivation from latency. Using a novel HIV-1 viral vector with an interchangeable Rev cassette, we engineered viruses with two diverse Rev functional activities and demonstrated that higher Rev-RRE activity confers greater viral replication capacity while maintaining a constant level of Nef expression. In addition, a low Rev activity virus rapidly acquired a compensatory mutation in the RRE that significantly increased Rev-RRE activity and replication. In a latency model, proviruses with differing Rev-RRE activity levels varied in the efficiency of viral reactivation, affecting both initial viral release and subsequent replication kinetics. These results demonstrate that activity differences in the Rev-RRE axis among different viral isolates have important implications for HIV replication dynamics and persistence. Importantly, our findings indicate that bolstering Rev/RRE activity could be explored as part of latency reversal strategies in HIV cure efforts.
Authors
- Godfrey Dzhivhuho (ORCID: https://orcid.org/0000-0001-5795-4049)
- Jing Huang (ORCID: https://orcid.org/0000-0002-3455-5966)
- David Rekosh (ORCID: https://orcid.org/0000-0003-3662-4176)
- Patrick Jackson (ORCID: https://orcid.org/0000-0002-7003-018X)
- Ethan Honeycutt (ORCID: https://orcid.org/0000-0003-3816-7730)
- Flávio da Silva Mesquita (ORCID: https://orcid.org/0000-0002-4200-7943)
- Marie-Louise Hammarskjöld
Institutions
- University of Virginia (US)
Publication Details
- Journal
- PLoS Pathogens
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1371/journal.ppat.1012885
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- School of Medicine, University of Virginia
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases